Drugs Used Treat Lower Respiratory Disease

Front 1

narrow air passages, create turbulence, and increase resistance to airflow

Back 1

obstructive airway disease

Hint 1

disease causes narrowing of airways through smooth muscle constriction

Front 2

lung expansion is limited from loss of elastricity or physical deformity chest

Back 2

restrictive airway disease

Hint 2

pulmonary fibrosis

Front 3

smooth muscle constriction

Back 3

bronchospasm

Hint 3

narrowing of airways

Front 4

human lung contain ___ to __million sacs for gaseous exchange

Back 4

300 to 500

Hint 4

equal to that of tennis court

Front 5

multiply number of packs cigarettes smoke per day times number of years smoking

Back 5

hx of smoking

Hint 5

11/2 packs per day for 20 years 1.5 x 20 = 30 packs hx of smoking

Front 6

make sure pt have strength and dexterity

muscle cordination is not fully develop as young child

dexterity has demished older adults

Back 6

use a spacer meds administer by inhalation

Hint 6

have patient demostrate use of inhaler each visit

Front 7

confirm patient exhales __before initiating first inhalation of meds and hold breath ___secs during inhalation

Back 7

completely , 10 secs

Hint 7

bronchodilator and steroid use bronchodilator first wait few minutes do steroids

Front 8

cats, dogs, and birds are frequently a source of

Back 8

asthma triggers

Hint 8

pets remove or kept outside

Front 9

all smoking must ---- provide smoking ___ education and counseling

Back 9

cease, cessation

Hint 9

health maintenance

Front 10

specific nutritional supplement patients respiratory diseases

Back 10

pulmocare

Hint 10

may be ordered

Front 11

what type of precaution take when taking pulmocare supplement

Back 11

avoid caffeine weak diuretic

diuretics promote thickning lung secreation

milk and chocolate

Hint 11

increase thickness of secretios making them more diffucult expectorate lungs

Front 12

expectorant that acts by enhancing the output of respiratory tract fluid. the increase flow of secretions ________

Back 12

decreases mucus viscosity and promotes ciliary action

Front 13

a combination of cilliary action and coughing

Back 13

expels phlegmfrom the pulmonary system Robitussinn

Hint 13

guifenesin Robitussin

Front 14

guaifenesin shoul not be given to a patient if there is

Back 14

dry persistant cough last more that week

accompanies asthma, bronchitis, and emphysema or cough accompanied by excessive production phlegm

Hint 14

Rubitussin

Front 15

saline solution varying concentrations can be effective expectorants when administered by

Back 15

nebulization 0.4-65% sodium chloride deeper penetration distant airways

Hint 15

hypotonic solution

Front 16

hydrates and stimulates a productive cough by irritating the respiratory passages

Back 16

1.8 sodium chloride

Hint 16

hypertonic solution

Front 17

solution administered by nebulization are used to hydrate respiratory secretions

Back 17

0.9 sodium chloride

Hint 17

isotonic saline solution

Front 18

what is used treat acetaminophen toxicity

Back 18

acetylcysteine

Hint 18

prevent renal failure secondary contrast media used visualize organs or locations blood clots

Front 19

what inactivates most antibiotics

Back 19

acetylcysteine

Hint 19

do not mix together for aerosol administration

Front 20

what allow easier removal of secretions by coughing, percussion, and postural drainage

Back 20

reduce viscosity

Front 21

reverse airway constriction caused by acute and chronic bronchial asthma, bronchitis and emphysema

Back 21

beta-adrenergic bronchodilators

Front 22

rapid onset used treat acute bronchospasm

Back 22

short acting beta agonists

Hint 22

alberturol, levalbuterol, pirbuterol, terbutaline, metaprotereenol

Front 23

onset 5 to 15 minutes duration of 24 hours given once daily

Back 23

formoterol indacaterol and olodaterol

Front 24

serious adverse reaction beta adrenergic bronchodilators

Back 24

tachycardia, palpations

Hint 24

report 20 or more beats /min

Front 25

what is administered by aerosol inhalation and produces___

Back 25

bronchodilation

ipratropium bromide

Hint 25

inhibition cholinergic receptors bronchial smooth muscle blocking bronchoconsrictor vagal efferent pulses.

Front 26

what is used as a long term treatment reversible bronchospasm associated COPD

Back 26

ipratropium bromide

Atrovent

Front 27

before using ipratropium bromide Atrovent check medical record

Back 27

hx closed angle glaucoma

Front 28

how to administer tiotropium

Back 28

clear throat and mouth sputum

breathe out completely

do not breathe into mouth piece at any time

raise handihaler device to mouth and close lips tighttly around the mouthpiece

keep head upright postion and breathe in slowly and deeply

rate suffiently to hear capsule vibrate

breathe in to lungs full and hold breathe long as comfortable

Hint 28

at same time take handihaler device out

Front 29

use tiotropium bromide Spirival with caution in patients with potential for ___

Back 29

closed angle glaucoma

prostatic hyperplasia

bladder neck obstruction

Front 30

should not be used for initial treatment acute episodes of bronchospasm in whic rapid response is required

Back 30

ipratropium bromide Atrovent

Front 31

what is a selective and competitive receptor antagonist of the cysteinyl leukotriene receptor. this receptor that leukotriene d4 stimulates trigger symptoms of asthma

Back 31

montelukast Singular

Hint 31

chronic and prophylactic treatment asthma conjunction with other meds

Front 32

what is first leukotriene receptor antagonist to be introduce treatment of asthma

Back 32

zafirlukast

Accolate

Front 33

decreased incident of asthma exacerbations in these patients moderatt to severe persistent asthma have positive ________and that are not adequately controlled with

Back 33

positive skin reaction to a perennial airborne allergen

with inhaled corticosteroids

Hint 33

not used acute brochospasm or status asthmaticus

Front 34

within hours of first or subsequent doses of _____allergic reactions and anaphylaxis have occured

Back 34

omalizumab Xolair

Front 35

symptoms of allergic reaction and anaphylaxis

Back 35

urticaria and throat and or tongue edema

Front 36

how threat allergic reaction and or anaphylaxis

Back 36

oxygen, epinephrine, diphenhydramine should be available

Hint 36

omalizumab Xolair

Front 37

studies that used assess the capability of patients lungs thorax and respiratory muscles for moving volumes of air during inhalation and exhalation

Back 37

spirometry

Front 38

chronic inflammation in airways and lung tissue due to noxious particles and gases are

Back 38

COPD and CALD

Hint 38

chronic airlow limitation disease

Front 39

alveolar sacs lose elasticityy and collapse during exhallation trapping ir wihtin lung

Back 39

emphysema

Hint 39

disease of alveolar tissue destruction without fibrosis

Front 40

lung expansion is limited from loss of elasticity example

Back 40

restrictive airway disease example pulmonary fibrosis